Changping, Beijing, China Chang Development appeared to be the Corporate Investor, which was created in 2015. The company was established in Asia in China. The leading representative office of defined Corporate Investor is situated in the Changping.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Artificial Intelligence, Machine Learning. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the various public portfolio startups of the fund, we may underline Deepwise
The top activity for fund was in 2019. The fund is generally included in less than 2 deals every year.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Chang Development, startups are often financed by Tendence Capital, Kinzon Capital, Dalton Venture. The meaningful sponsors for the fund in investment in the same round are Sunshine Insurance Group, Sunland Fund, Silk Road Huachuang.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Aquarius Equity Partners | England, Manchester, United Kingdom |
| Biotech Fund Flanders | Antwerp, Antwerpen, Belgium |
| Crypto Dorm Fund | - |
| INCA VENTURES | - |
| Long Ridge Equity Partners | New York, New York, United States |
| Milkbox Partners | New York, New York, United States |
| PJC | Boston, Massachusetts, United States |
| Qinxing Technology | China, Guangdong Province, Huizhou |
| Sanquin Blood Supply Foundation | - |
| Unitus Ventures | Seattle, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TOPI Imaging Technology | $30M | 14 Dec 2021 | Beijing, Beijing, China | ||
Jifan Biotechnology | $15M | 13 Dec 2021 | Changping, Beijing, China | ||
Leto Laboratories | $15M | 16 Oct 2020 | China, Beijing | ||
Deepwise | 10 Jun 2019 | China, Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TOPI Imaging Technology | $30M | 14 Dec 2021 | Beijing, Beijing, China | ||
Jifan Biotechnology | $15M | 13 Dec 2021 | Changping, Beijing, China | ||
Leto Laboratories | $15M | 16 Oct 2020 | China, Beijing | ||
Deepwise | 10 Jun 2019 | China, Beijing |
